Bottom line
MEDX vs SCHLX: the short answer
MEDX (Horizon Kinetics Medical ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 51% by weight.
MEDX is cheaper at 0.85% vs 1.06% — a difference of $21 a year per $10,000 invested.
Updated Nov 19, 2026
MEDX vs SCHLX side by side
| MEDX | SCHLX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Roundhill | DWS (Xtrackers) |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.85% | 1.06% |
| Annual cost per $10k | $85 | $106 |
| 10-yr cost on $10k (prospectus) | $1,049 | $1,294 |
| Max front load | None | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +28.4% | — |
| 5-yr return (annualized) | +5.8% | — |
| 10-yr return (annualized) | +5.7% | — |
| Best quarter | +15.0% | — |
| Worst quarter | −12.9% | — |
| Net assets (fund) | $19.1M | $231.8M |
| Number of holdings | 33 | 65 |
| Portfolio turnover | % | 2% |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
10 of MEDX's top 25 holdings also appear in SCHLX's top 25.
| Holding | MEDX | SCHLX |
|---|---|---|
| Eli Lilly & Co | 18.46% | 13.85% |
| AbbVie Inc | 8.85% | 4.90% |
| Novartis AG | 6.89% | 2.90% |
| Johnson & Johnson | 5.59% | 6.19% |
| AstraZeneca PLC | 4.98% | 3.80% |
| Bristol-Myers Squibb Co | 4.42% | 1.50% |
| Merck & Co Inc | 3.96% | 4.85% |
| Amgen Inc | 3.91% | 2.88% |
| Pfizer Inc | 2.86% | 1.17% |
| Regeneron Pharmaceuticals Inc | 2.06% | 1.43% |
Source: SEC Form N-PORT
MEDX top 10
- Eli Lilly & Co — 18.46%
- US Bank Mmda - Usbgfs 7 — 9.19%
- AbbVie Inc — 8.85%
- Novartis AG — 6.89%
- Johnson & Johnson — 5.59%
- Alkermes PLC — 5.53%
- AstraZeneca PLC — 4.98%
- Ionis Pharmaceuticals Inc — 4.53%
- Bristol-Myers Squibb Co — 4.42%
- Merck & Co Inc — 3.96%
SCHLX top 10
- Eli Lilly & Co — 13.85%
- Johnson & Johnson — 6.19%
- UnitedHealth Group Inc — 5.73%
- AbbVie Inc — 4.90%
- Merck & Co Inc — 4.85%
- AstraZeneca PLC — 3.80%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Amgen Inc — 2.88%
- Gilead Sciences Inc — 2.78%
FAQ
What is the difference between MEDX and SCHLX?
MEDX (Horizon Kinetics Medical ETF) and SCHLX (DWS Health and Wellness Fund) share a meaningful slice of their top holdings — about 51% by weight. MEDX is cheaper at 0.85% vs 1.06% — a difference of $21 a year per $10,000 invested.
Which is cheaper, MEDX or SCHLX?
MEDX has the lower expense ratio (0.85%).
Should I own both MEDX and SCHLX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.